作者:
Chowdary, P. [1]
;
Georgiev, P. [2]
;
Mant, T. [3]
;
Creagh, M. D. [4]
;
Lissitchkov, T. [5]
;
Bevan, D. [6]
;
Austin, S. [7]
;
Hay, C. R. [8]
;
Hegemann, I. [9]
;
Kazmi, R. [10]
;
Ragni, M. V. [11]
;
Rangarajan, S. [12]
;
Soh, C. -H. [13]
;
Akinc, A. [14]
;
Monpara, A. ;
Madigan, K. ;
Pasi, K. J.
作者单位:
Barts & London Queen Marys Sch Med & Dent, Royal London Haemophilia Ctr, London, England
[1]
Royal Cornwall Hosp NHS Trust, Truro, England
[2]
Alnylam Pharmaceut, Cambridge, MA USA
[3]
Univ Multiprofile Hosp Act Treatment Sveti Georgi, Plovdiv, Bulgaria
[4]
Univ Hosp, Zurich, Switzerland
[5]
Quintiles Drug Res Unit, London, England
[6]
Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[7]
Hampshire Hosp NHS Fdn Trus, Haemophilia Haemostasis & Thrombosis Ctr, Basingstoke, Hants, England
[8]
Royal Free Hosp, London, England
[9]
Guys & St Thomas Hosp NHS Trust, London, England
[10]
St Georges Healthcare NHS Trust Haemophilia Ctr, London, England
[11]
Univ Pittsburgh, Pittsburgh, PA USA
[12]
Manchester Royal Infirm, Machester, England
[13]
Clin Hematol Clin Specialized Hosp Act Treatment, Sofia, Bulgaria
[14]
发布时间
2017-05-06